Dark

MBRX
Moleculin Biotech, Inc.
stock NASDAQ

Market Open

Jul 29, 2026 10:48:05 AM EDT

1.38USD-37.273%(-0.82)828,620

1.34Bid 1.36Ask 0.02Spread

Pre-market

Jul 27, 2026 9:15:30 AM EDT

2.07USD-2.387%(-0.05)0

After-hours

Jul 28, 2026 4:11:30 PM EDT

2.20USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

9.68M

Headquarters

Houston, Texas, USA

Industry

Biotechnology

Next Earnings

Aug 11, 2026 (13d)

Last Split

Dec 1, 20251for25reverse

OMER XLV

MBRX Stats

Avg. Vol. 10 Day

84,589

Avg. Vol. 30 Day

782,738

Market Cap

9,679,050

Shares Out.

7,065,000

On/Off Exchange

57%/43%

6 Month Beta

1.13

1 Year Beta

1.09

2 Year Beta

1.22

3 Year Beta

1.06

52 Week Low

1.79

52 Week High

18.75

SMA50

2.50

SMA200

4.63

1 Week

-34.76%

1 Month

-61.63%

3 Month

-45.42%

6 Month

-67.99%

1 Year

-92.33%

2 Year

-98.36%

5 Year

-99.89%

Profile

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. the other portfolio targets the metabolism of tumors.

MBRX Stock Summary

Moleculin Biotech, Inc. (NASDAQ:MBRX) stock price today is $1.38, and today's volume is 828,620. MBRX is down -37.273% today. The 30 day average volume is 782,738. MBRX market cap is 9.68M with 7,065,000 shares outstanding.